Nkgen Biotech, Common Stock Alpha and Beta Analysis
| NKGN Stock | 0.05 0 1.96% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as NKGen Biotech, Common. It also helps investors analyze the systematic and unsystematic risks associated with investing in NKGen Biotech, over a specified time horizon. Remember, high NKGen Biotech,'s alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to NKGen Biotech,'s market risk premium analysis include:
Beta 6.83 | Alpha 14.27 | Risk 61.17 | Sharpe Ratio 0.24 | Expected Return 14.76 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
NKGen |
NKGen Biotech, Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. NKGen Biotech, market risk premium is the additional return an investor will receive from holding NKGen Biotech, long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in NKGen Biotech,. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate NKGen Biotech,'s performance over market.| α | 14.27 | β | 6.83 |
NKGen Biotech, expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of NKGen Biotech,'s Buy-and-hold return. Our buy-and-hold chart shows how NKGen Biotech, performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.NKGen Biotech, Market Price Analysis
Market price analysis indicators help investors to evaluate how NKGen Biotech, pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NKGen Biotech, shares will generate the highest return on investment. By understating and applying NKGen Biotech, pink sheet market price indicators, traders can identify NKGen Biotech, position entry and exit signals to maximize returns.
NKGen Biotech, Return and Market Media
Price Growth (%) |
| Timeline |
About NKGen Biotech, Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including NKGen or other pink sheets. Alpha measures the amount that position in NKGen Biotech, Common has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
NKGen Biotech, Upcoming Company Events
As portrayed in its financial statements, the presentation of NKGen Biotech,'s financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, NKGen Biotech,'s leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of NKGen Biotech,'s public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of NKGen Biotech,. Please utilize our Beneish M Score to check the likelihood of NKGen Biotech,'s management manipulating its earnings.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with NKGen Biotech,
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Other Information on Investing in NKGen Pink Sheet
NKGen Biotech, financial ratios help investors to determine whether NKGen Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NKGen with respect to the benefits of owning NKGen Biotech, security.